`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________
`
`AQUESTIVE THERAPEUTICS, INC.,
`
`Petitioner,
`
`v.
`
`NEURELIS, INC.,
`
`Patent Owner.
`
`____________________
`
`Case IPR2019-00451
`Patent 9,763,876
`____________________
`
`NEURELIS REQUEST FOR ORAL ARGUMENT
`37 CFR §42.70(a)
`
`
`
`Pursuant to the scheduling order (Paper 9, 6), Patent Owner (“Neurelis”)
`
`requests oral argument on all pending issues, including whether to terminate the
`
`review, whether to strike the reply of the Petitioner (Aquestive) or the declaration
`
`of its expert Dr. Wermeling, and any motion to exclude.
`
`Because most of its participants are on the West Coast, Neurelis respectfully
`
`requests an afternoon (Eastern) argument.
`
`Neurelis anticipates that eight (8) individuals (including counsel) will attend
`
`for Neurelis, if in-person attendance becomes feasible.
`
`Date: March 31, 2020
`
`Respectfully submitted,
`
`
`/Jeffrey W. Guise /
`Jeffrey W. Guise, Reg. No. 34,613
`Counsel for Neurelis
`
`-1-
`
`IPR2019-00451
`
`
`
`CERTIFICATE OF SERVICE
`I certify this paper was served electronically today to the following
`
`addresses:
`
`
`
`Daniel A. Scola, Jr.
`Michael I. Chakansky
`James F. Harrington
`Matthew J. Solow
`John T. Gallagher
`HOFFMANN & BARON, LLP
`
`dscola@hbiplaw.com
`mchakansky@hbiplaw.com
`jharrington@hbiplaw.com
`msolow@hbiplaw.com
`jgallagher@hbiplaw.com
`876IPR@hbiplaw.com
`
`Date: March 31, 2020
`
`/Michelle Lee /
`Michelle Lee
`
`-2-
`
`IPR2019-00451
`
`